Cytotoxicity Effects of Different Surfactant Molecules Conjugated to Carbon Nanotubes on Human Astrocytoma Cells by Dong, Lifeng et al.
NANO EXPRESS
Cytotoxicity Effects of Different Surfactant Molecules Conjugated
to Carbon Nanotubes on Human Astrocytoma Cells
Lifeng Dong Æ Colette M. Witkowski Æ
Michael M. Craig Æ Molly M. Greenwade Æ
Katherine L. Joseph
Received: 25 June 2009/Accepted: 19 August 2009/Published online: 4 September 2009
 to the authors 2009
Abstract Phase contrast and epiﬂuorescence microscopy
were utilized to monitor morphological changes in human
astrocytoma cells during a time-course exposure to single-
walled carbon nanotube (SWCNT) conjugates with dif-
ferent surfactants and to investigate sub-cellular distribu-
tion of the nanotube conjugates, respectively. Experimental
results demonstrate that cytotoxicity of the nanotube/sur-
factant conjugates is related to the toxicity of surfactant
molecules attached on the nanotube surfaces. Both sodium
dodecyl sulfate (SDS) and sodium dodecylbenzene sulfo-
nate (SDBS) are toxic to cells. Exposure to CNT/SDS
conjugates (0.5 mg/mL) for less than 5 min caused chan-
ges in cell morphology resulting in a distinctly spherical
shape compared to untreated cells. In contrast, sodium
cholate (SC) and CNT/SC did not affect cell morphology,
proliferation, or growth. These data indicate that SC is an
environmentally friendly surfactant for the puriﬁcation and
dispersion of SWCNTs. Epiﬂuorescence microscopy anal-
ysis of CNT/DNA conjugates revealed distribution in the
cytoplasm of cells and did not show adverse effects on cell
morphology, proliferation, or viability during a 72-h
incubation. These observations suggest that the SWCNTs
could be used as non-viral vectors for diagnostic and
therapeutic molecules across the blood–brain barrier to the
brain and the central nervous system.
Keywords Carbon nanotubes   Surfactants  
Cytotoxicity   Astrocytoma cells   Blood–brain barrier  
Brain tumors   Central nervous system   Gene therapy  
Non-viral gene vector
Introduction
In recent years, increasing attention is being directed to the
structure, maintenance, and pathological disturbance of the
blood–brain barrier (BBB), particularly with regard to
enlarging a conceptual understanding of the signaling
pathways that exist between and among the constituent
cells of the BBB (i.e., endothelial cells, astrocytes, peri-
vascular cells, and pericytes) [1]. A tight BBB can effec-
tively protect the brain from many common bacterial and
selected, non-tissue speciﬁc viral infections, but can hinder
also the delivery of many effective diagnostic and thera-
peutic agents to the brain. Defeating this latter capability of
the BBB has been a particular interest of the pharmaceu-
tical industry, especially with regard to delivery of suc-
cessful chemotherapy against central nervous system
(CNS) tumors and other CNS neuropathologies [2].
Recently, an increasing number of observations have
demonstrated that nanoscale materials can be used as non-
viral vectors to deliver therapeutic drugs and other small
molecules across the plasma membrane [3] or putatively
across the BBB [4–7]. The important implication of these
studies is this: when researchers or workers in the manu-
facturing sector handle nanoscale materials, these nanom-
aterials may not only remain on the skin and be inhaled
into the lungs, they could also be transported to the CNS.
Therefore, a critical evaluation of the potential cytotoxicity
of nanoscale materials on the brain must be executed
before we can safely use nanomaterials as drug vectors or
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Carbon nanotubes, especially single-walled carbon
nanotubes (SWCNTs), are among the most promising
nanoscale materials that have a broad range of applications,
including building blocks for future nanoscale devices and
vectors for drug delivery. Since their structures were
revealedbytransmissionelectronmicroscopybyIijimaetal.
in 1993 [8], SWCNTs have been extensively investigated as
buildingblocksfornanoscaleelectronics,suchasﬁeldeffect
transistors (FET) [9, 10], interconnects [11], and electron
emitters [12]. In addition, a number of in vivo and in vitro
experiments showed that SWCNTs can effectively deliver
drugs, antibodies, and other biologically active molecules
into cells and tissues [13, 14]. In order to be useful for these
promising applications, SWCNTs need to be puriﬁed and
dispersed into individual nanotubes since synthesized
nanotubes occur in the form of bundles with accompanying
impurities such as metal catalyst particles and amorphous
carbon debris. One method to do this is by surfactant sta-
bilization of the hydrophobic nanotube surfaces, which
overcomes the van der Waals forces among the nanotubes
and results in suspensions of individual SWCNTs. Several
surfactants, such as sodium dodecyl sulfate (SDS) [15, 16],
sodium dodecylbenzene sulfonate (SDBS) [16–19], and
sodium cholate (SC) [20], have been demonstrated to efﬁ-
cientlydispersebundlednanotubesintoaqueoussuspensions
of individual nanotubes. It is critical to understand the tox-
icity of the nanotube/surfactant conjugates since these
reagents are increasingly being used in manufacturing
industriesandresearchlaboratories.Toourknowledge,there
has been no systematic study concerning cytotoxicity of
SWCNTs, especially carbon nanotube conjugates with the
extensively used SDS, SDBS, and SC surfactants, on the
brain and the CNS. In the brain, astrocytes serve important
roles in the BBB [1] and their functional repertoire keeps
expanding. For example, astrocytes are involved in regu-
lating endothelial tight junctions [21], mediating cortical
vasodilation during neural activity [22], and propagating
intercellular Ca
2? signaling waves between astrocyte net-
works and distant neurons [23]. For this study exploring the
cytotoxic effects of different surfactants conjugated to
SWCNTs on the brain, we selected 1321N1 human astro-
cytoma cells because they model an important cell constit-
uent of the BBB, and they avoid the difﬁculties with
establishing and maintaining primary astrocyte cultures.
Recently, we utilized the CellTiter 96 Aqueous One
Solution (Promega) assay to study quantitatively the
cytotoxicity of SWCNT conjugates with SC, SDS, SDBS,
and single-stranded DNA (ssDNA) molecules on 1321N1
human astrocytoma cells [24]. Brieﬂy, the toxicity of car-
bon nanotube conjugates was mainly controlled by the
surfactant molecules attached to the nanotube surfaces. The
conjugates of SWCNTs with SDS and SDBS were toxic to
human astrocytoma cells, yet the nanotubes alone and the
nanotube conjugates with SC and ssDNA did not generate
obvious toxic responses. Since a cell viability or cytotox-
icity assay requires at least 10 min to several hours of
incubation to generate a measurable signal (1–2 h for the
CellTiter 96 Aqueous One Solution), there could be some
interactions of the nanotubes as well as their conjugates
with the assay components. Consequently, we report here
an attempt to assess the cytotoxicity of SWCNT conjugates
for human astrocytoma cells by extending our previous
observations to the sub-10 min reaction time, by direct
observation with phase contrast light microscopy, and to
conﬁrm penetration and localization of an SWCNT con-
jugate (ssDNA labeled with Cy5 ﬂuorochrome) in astro-
cytoma cell cytoplasm.
Materials and Methods
Preparation of SWCNT Conjugates
To prepare an aqueous SWCNT solution, 1 mg of nanotube
powder (BuckyUSA Company) was dispersed in 1 mL of 1
wt% surfactant (SDS, SDBS, or SC) or Cy5-labeled single-
strandedDNA [(GT)15, 1 mg/mL]solution.Thesuspension
was sonicated (Branson Ultrasonic, 130 W) for 60 min and
centrifuged(Eppendorf5415R)at16,000gfor60 min.After
centrifugation, the supernatant, containing individual
SWCNTs, was decanted. The precipitates, which contained
catalystparticles,bundlednanotubes,andamorphouscarbon
debris, were discarded, and the nanotube concentration was
determined by UV–Vis spectrophotometer.
Cell Culture and Microscopy
Human 1321N1 astrocytoma cells were maintained and
assayed in Dulbecco’s modiﬁed Eagle’s medium (Invitro-
gen) supplemented with 10% fetal bovine serum (FBS) and
1% penicillin–streptomycin, and incubated at 37 Ci na
humidiﬁed 5% CO2 incubator.
To assess cell morphology over an exposure time-
course, 1,000 cells/well (estimated by a hemocytometer)
were seeded in 100 lL/well of culture medium in 96-well
culture plates and incubated at 37 C in a humidiﬁed 5%
CO2 incubator for 24 h to allow the cells to settle and
adhere to the wells. After the cells were established, 5.0 lL
of 1% surfactant alone or nanotube/surfactant solution was
added to selected wells in triplicate. Observation of mor-
phological changes was conducted under ambient atmo-
sphere at room temperature (22–24 C) using an Olympus
IX70 inverted microscope equipped with phase contrast
optics.
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well in 500 lL/well of culture medium were seeded onto
11-mm glass coverslips in 24-well culture plates with
10.0 lL of CNT/DNA conjugate solution added to the
wells. After a 72-h incubation, the cells were washed three
times with standard phosphate-buffered saline, ﬁxed with
4.0% paraformaldedyde for 5 min, counterstained with 40,
6-diamidino-2-phenylindole (DAPI), and mounted on glass
slides with Immunomount. Fixed cells were observed using
an Olympus BX60 epiﬂuorescence microscope equipped
with a Retigia EX CCD camera. Images were acquired and
processed with ImagePro Plus (Media Cybernetics)
software.
Results and Discussion
Cytotoxicity of SWCNT Conjugates with Different
Surfactants
The morphology of human astrocytoma cells exposed to the
SWCNT/surfactant conjugates, CNT/SC, CNT/SDBS, or
CNT/SDS, was similar to the cellular morphology demon-
strated by exposure to the corresponding surfactant solution
cargoes SC, SDBS, or SDS, respectively (Fig. 1). Without
the introduction of any surfactants or surfactant/nanotube
conjugates, control cells exhibit normal morphology and
growth even under ambient atmosphere at room tempera-
ture for several hours (Fig. 1a, taken at 1 h of incubation
under ambient atmosphere). Cells exposed to DNA, SC, and
CNT/SC (Fig. 1b–d) demonstrate normal cell morphology
when compared to the control conditions (Fig. 1a). Cells
undergoing mitosis are indicated by arrows. Phase contrast
images in Fig. 1 suggest that SC and the nanotube conju-
gates with DNA and SC had no effect on proliferation or
viability of human astrocytoma cells within 60 min.
In contrast, cells exposed to SDBS, CNT/SDBS, SDS,
and CNT/SDS demonstrate irregular cell morphology at
the 30 min time point, and no mitotic cells were observed.
Cells exposed to SDBS (Fig. 1e) and CNT/SDBS (Fig. 1f)
for 30 min show a distinct spherical morphology with
cytoplasmic processes apparently retracted compared to
untreated or SC-exposed cell morphology. Cells exposed to
SDS (Fig. 1g) and CNT/SDS (Fig. 1h) for 30 min exhibit a
similar spherical morphology with cellular debris visible in
the medium. The phase contrast images in Fig. 1 suggest
that SDBS and SDS and their nanotube conjugates
adversely affected cell morphology and growth within
30 min of exposure.
The anionic surfactants SC, SDBS, and SDS exhibited
different inﬂuences on cell morphology and viability. This
indicates that the toxicity of nanotube/surfactant conjugates
was controlled by the surfactant molecules attached on the
nanotube surface, but was not related to their anionic
characteristics. The SC molecules alone had no effect on
cell morphology or growth; apparently, the conjugates of
CNT/SC are not toxic to the cells. Human astrocytoma
cells did demonstrate a toxic response to conjugates of
CNT/SDBS and CNT/SDS because both SDBS and SDS
are toxic to the cells. Preliminary observations indicate that
SDS (Fig. 1g, h) may be more toxic to the astrocytoma
cells than SDBS (Fig. 1e, f) since the phase contrast
observations demonstrate cellular debris, possibly indicat-
ing cell lysis, at 30 min exposure.
Time-Course Morphological Changes Induced by
an Exposure to CNT/SDS Conjugates
CNT/SDS conjugates affected cell viability within 30 min
of exposure (Fig. 1h). To further understand the earliest
appearance of morphological changes induced by nanotube/
conjugate exposure, a time-course study of changes was
recorded starting at time 0 min, at which time the CNT/SDS
conjugates were introduced into the growth medium
(Fig. 2a). Cells were observed at 2 min after introduction of
the CNT/SDS conjugates, at which time a few cells dem-
onstrated retraction of their cytoplasmic processes
(Fig. 2b). After 5 min, a majority of cells assumed a nascent
spherical morphology with accompanying process retrac-
tion (Fig. 2c). At 10 min, virtually all cells demonstrated
reduced contact with the substratum and assumption of a
spherical morphology (Fig. 2d). Observations at 25 and
75 min revealed cellular debris in the culture medium
(Fig. 2e).
The time-course analysis shows that exposure to CNT/
SDS conjugates rapidly (within 2 min) and distinctly
affected cell morphology. Observations included potential
loss of membrane integrity, retraction of cytoplasmic pro-
cesses, reduced cell-to-substratum adhesion, putative cell
shrinkage, and generation of cellular debris. Astrocytoma
cells exposed to CNT/SDS conjugates demonstrate char-
acteristic morphological changes that are reminiscent of
apoptosis [25].
There are alternative interpretations regarding the tox-
icity of carbon nanotubes for both in vivo and in vitro
generated data. Some experimental results indicate that
introduction of carbon nanotubes into the growth medium
does not affect cell proliferation and viability [26–35], yet
other experiments demonstrate that structural variants of
carbon nanotubes do affect cell proliferation [36–39]. Our
time-course analysis (Figs. 1, 2) demonstrates that the
cytotoxicity of the tested nanotube conjugates was con-
trolled by the surfactants attached to the nanotube surface,
and nanotubes alone do not affect cell proliferation and
growth.
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The nanotube conjugates with SC and ssDNA did not
affect cell proliferation and growth. These observations
could be attributed to the conjugates remaining in the
extracellular environment and not being taken into astro-
cytoma cell cytoplasm. In order to explore whether the
nanotube conjugates can enter the cells or not, as well as
cellular distributions of the conjugates if they enter the
cells, we utilized epiﬂuorescence microscopy to initiate the
exploration, and the Cy5 ﬂuorochrome attached to the
CNT/DNA conjugate was used to monitor the uptake of
these nanotube conjugates.
When the cells were exposed to the CNT/DNA conju-
gates for a time period less than 24 h, the ﬂuorescence
signal was quite weak. In order to obtain a strong signal
and to investigate cytotoxicity of the nanotube conjugates
for a longer time period, adhering astrocytoma cells were
Fig. 1 Digital phase contrast
images of human astrocytoma
cells exposed to surfactants or
nanotube/surfactant conjugate
solutions under ambient
atmosphere at room
temperature: a control, 60 min;
b CNT/DNA, 60 min; c SC,
60 min; d CNT/SC, 60 min; e
SDBS, 30 min; f CNT/SDBS,
30 min; g SDS, 30 min; and h
CNT/SDS, 30 min. The
concentrations of surfactants
(b–h) and the SWCNTs (b, d, f,
and h) were 0.5 mg/mL and
2 lg/mL, respectively. Arrows
indicate proliferating cells. All
images were acquired at 2009
magniﬁcation directly from the
wells. Scale bar: 100 lm
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72-h incubation, the cells exhibit normal morphology and
proliferation (Fig. 3a). The CNT/DNA-Cy5 conjugates
were observed within the cytoplasm (Fig. 3b–d), indicating
that the conjugates were effectively transported into the
astrocytoma cells. Infrequently, ﬂuorescence was detected
in a punctate pattern within the cell cytoplasm, with ﬂuo-
rescence signal detected over the nuclear region of some
cells (Fig. 3d). The question about the entry of the labeled
conjugate into, or exclusion from, the nuclear compart-
ments could not be resolved from these images at this time.
No ﬂuorescence was detected from untreated control cells
(data not shown). Some cytoplasmic regions demonstrate
more intense ﬂuorescence; this focal intensity may repre-
sent clusters or bundles of the conjugates. The ﬂuorescence
microscopy analysis demonstrates that CNT/DNA-Cy5
conjugates were distributed within the cytoplasm and did
not affect cell morphology. These results suggest that
SWCNTs could be used as vectors for diagnostic and
imaging contrast agent molecules into the brain and the
CNS across the blood–brain barrier since carbon nanotubes
can convey the ssDNA molecules into the cells, and their
conjugates did not affect the proliferation and growth of
astrocytoma cells. The next step is to investigate how to
target delivery of therapeutic and diagnostic agents and
how to release agent molecules inside the cells.
Conclusions
Time-course microscopy analysis demonstrates that the
cytotoxicity of nanotube/surfactant conjugates is related to
the toxicity of the surfactant molecules attached on the
nanotube surfaces. Human astrocytoma cells, exposed to
SDBS or SDS in the growth medium, experienced mor-
phological changes including potential loss of plasma
Fig. 2 Phase contrast images of
a time-course of morphological
events observed in astrocytoma
cells after exposure to
0.5 mg/mL CNT/SDS conjugate
solutions for a 0 min; b 2 min;
c 5 min; d 10 min; e 25 min;
and f 75 min. All images were
acquired at 1009 magniﬁcation.
Scale bar: 200 lm
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shrinkage, and generation of cellular debris. Cells exposed
to 0.5-mg/mL CNT/SDS conjugates exhibited nascent
morphological alterations within 2 min. Our data indicate
that SC could be used as an environmentally friendly
reagent for the dispersion and puriﬁcation of SWCNTs.
Epiﬂuorescence microscopy analysis of CNT/DNA conju-
gates indicates that these conjugates were efﬁciently
delivered into cells and distributed within the cytoplasm,
although the question of CNT conjugate penetration into
nuclei remains unresolved at this time. The precise mech-
anism for uptake of SWCNTs and SWCNT conjugates into
the cytoplasm of any cell type also remains unelucidated.
Since toxicity questions exist for the surfactants used to
disperse other nanoscale materials [40], the experimental
approach outlined in our study can be used to evaluate the
cytotoxicity of other nanoscale particles as well. SWCNTs
could be developed as non-viral vectors for diagnostic and
therapeutic molecules into the brain and the CNS across the
blood–brain barrier since their conjugates with ssDNA do
not affect the proliferation and growth of astrocytoma cells.
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